2022 Schedule of Events

Schedule of Events


PLEASE NOTE: The schedule is preliminary, tentative, and subject to change. We will live ‎stream and record keynote presentations and select breakout sessions for virtual ONLY ‎attendee participation. Pre-conference Workshops will be held onsite, for “in-person” only ‎participation.  Virtual Registration for the conference will be offered separately in early 2022 ‎for those who cannot or prefer not to travel. Thank you for your patience as navigate and ‎accommodate.‎




TUESDAY, MARCH 22, 2022‎

5:00pm - 7:00pm ‎        Registration Open



8:00am - 6:00pm ‎       Registration Open

8:00am - 9:00am        Workshop Attendee-only CONTINENTAL Breakfast



‎WS01: 9 am - 6:30 pm‎ - Full Day Workshop
BCIA Heart Rate Variability Biofeedback Certificate of Completion Workshop - Part 1

Presented By: ‎

  • Fredric Shaffer, PhD, BCB
  • Donald Moss, PhD, BCB, BCN
  • Inna Khazan, PhD, BCB

SESSION SYNOPSIS: This workshop is designed for biofeedback/neurofeedback practitioners, ‎psychologists, clinical counselors, clinical social workers, marriage and family therapists, nurses, ‎physicians, and other healthcare professionals and academicians interested in utilizing heart rate ‎variability (HRV) biofeedback in their practice or research. This workshop will cover 7.5 hours of the ‎BCIA HRV Biofeedback Certificate of Completion Blueprint and will cover cardiac anatomy and ‎physiology, respiratory anatomy and physiology, autonomic nervous system anatomy and physiology, ‎heart rate variability, HRV instrumentation, and HRV measurements. Attendees will review the ‎cardiac, respiratory, and autonomic anatomy and physiology that underlies HRV biofeedback. They ‎will discuss the central role of breathing in diverse disorders like anxiety, hypertension, and chronic ‎pain. Last, they will explain how HRV biofeedback restores autonomic balance and why this is ‎important to health and performance. Attendees will be able to discuss the meaning and sources of ‎HRV, and the correlates of low, normal, and high HRV. The presenters will explain the relationship ‎between aging, disease, and reduced HRV. Attendees will be able explain how to properly use HRV ‎instruments and interpret signals from blood volume pulse, electrocardiogram, and respirometer ‎sensors. The presenters will survey the major artifacts that contaminate recordings from these sensors ‎and show how to prevent or minimize them. Attendees will be able to describe and interpret HRV time ‎and frequency domain measurements.‎

  • Basic Science
  • Introductory
  • 50% Clinical/50% Research

learn how to explain the meaning of HRV, sources of HRV, factors that influence HRV, correlates of low ‎and normal HRV, and the benefits of increased HRV.‎
learn how to explain the physiological basis of HRV and the blood volume pulse (BVP), ‎electrocardiogram (ECG), and respirometer signals.‎
learn how BVP, ECG, and breathing sensors operate, how to perform tracking tests, and how to ‎identify and control artifacts.‎
learn BVP and ECG sensor placements with regard to cultural sensitivity.‎

TARGET AUDIENCE: Biofeedback/neurofeedback practitioners, psychologists, clinical counselors, ‎clinical social workers, marriage and family therapists, nurses, physicians, and other healthcare ‎professionals and academicians interested in utilizing heart rate variability (HRV) biofeedback in their ‎practice or research.‎

DIVERSITY CONSIDERATIONS: This workshop will address age and sex differences in HRV ‎measurements, how to explain HRV biofeedback to clients, and how to respect cultural diversity when ‎applying sensors.‎

‎9 am - 6 pm‎ - Full Day Workshop
WS02: Neurofield Advanced Course - Part 1

Presented By: ‎

  • Nicholas Dogris, PhD, QEEG-D, BCN
  • Tiff Thompson, PhD, R.EEG.T, BCN, QEEG-D, MFT

SESSION SYNOPSIS: The NeuroField Neuromodulation Advanced Training is designed to enhance your ‎skills in EEG and QEEG assessment, analysis, map interpretation, neuromodulation and treatment ‎planning in the NeuroField64 software platform, as well as Independent Components Analysis via ‎EEGlab and WinEEG. Case studies are welcome. This training is for intermediate to advanced ‎neurotherapy clinicians. ‎NeuroField64 combines Pulsed Electro Magnetic Field stimulation (pEMF), transcranial direct current ‎stimulation (tDCS), transcranial alternating current stimulation (tACS), and transcranial random noise ‎stimulation stimulation (tRNS), and transcranial Advanced Pink Noise Stimulation (tAPNS) modalities ‎with both Z-score and Amplitude EEG neurofeedback for the purpose of enhancing treatment ‎effectiveness.‎Dr. Dogris and Dr. Thompson will lecture regarding the application of NeuroField64 on various clinical ‎diagnoses including (but not limited to) Autism, ADHD, Mood Disorders, Substance Abuse, Sleep ‎Issues, TBI, and Concussion, as well as Peak Performance. Dr. Dogris and Dr. Thompson will conduct ‎live demonstrations of NeuroField64 and provide participants the opportunity to experience these ‎modalities during the training.‎

  • Clinical Interventions and Optimal Performance
  • Advanced
  • ‎50% Clinical/50% Research‎


  • Attendees should be able to identify different pathologies associated with EEG and QEEG ‎presentations
  • Attendees should be able to administer neuromodulation protocols, such as pEMF, tACS, tDCS, tRNS, ‎and Pink Noise Stimulation
  • Attendees should be able to use the neurofield system, including the synchronized application of ‎stimulation and neurofeedback.‎
  • Attendees should be able to list the mechanism of action for neurostimulation procedures.‎

TARGET AUDIENCE: Advanced Practitioners familiar with the Neurofield system

‎9 am - 6 pm‎ - Full Day Workshop
WS03: General Introduction to Biofeedback Peripherals

Presented By: ‎

  • Raymond Yust, Training/Show Coordinator
  • Frank DeGregorio, Technical Support Director ( Software IT Specialist)‎

SESSION SYNOPSIS: This 1 day workshop is for researchers and health professionals who want to learn ‎how to use peripheral biofeedback technology. The modalities that will be the focus of the session are ‎Surface Electromyography (SEMG), Respiration, Temperature, Skin Conductance, Heart Rate (from ‎blood volume pulse and electrocardiogram), and Heart Rate Variability.  A general overview of the ‎physiological basis for each peripheral measurement will be demonstrated. Participants will ‎participate in a " hands on" demonstration experience using the different modalities in conjunction ‎with audio and visual multimedia biofeedback displays.‎

  • Basic Science
  • Introductory
  • ‎100% Research‎


  • Increase exposure on the key features of the BioGraph Infiniti 6.6 software and hardware.‎
  • Describe software trouble shooting and technical specifications. Software suites include ‎Neurofeedback, Physiology, Rehab-Continence, Rehab- Muscle , HRV, and Reaction Time.‎
  • Demonstrate how to use different sensors including Surface Electromyography (SEMG), Respiration, ‎Temperature, Skin Conductance, Electroencephalography (EEG), Heart Rate and Electrocardiology ‎‎(EKG) with audio and visual multimedia biofeedback screens, sounds and games.‎
  • Explain what a virtual data-channel is and how it is related to the raw data from the physical sensor.  ‎Describe when proportional and inverse-proportional feedback should be used.  Define what is ‎artifact and why is artifact rejection necessary. Invite “hands-on” practice generating reports, review ‎data, and learn how to modify or customize and excising screen.‎

TARGET AUDIENCE: Licensed Health Care Professionals

DIVERSITY CONSIDERATIONS: The need for Biofeedback crosses all cultural diverse, competent, and ‎multicultural populations for which it serves.  It is an essential part of many therapeutic treatments ‎and clinical assessment protocols to treat stress related disorders as well as provide treatment for ‎incontinence and muscle rehabilitation, including sEMG-triggered stimulation. On the non-medical ‎side, it is also used in ergonomics, sports & peak performance and educational applications.




‎9 am - 1 pm‎ - Half Day Workshop
WS10: Integrating Bio- and Neurofeedback in Psychedelic Assisted Therapies

Presented By:

  • Jeff Tarrant, PhD, BCN
  • Heather Hargraves, MA., C.Psych.Assoc. (SP), NMI-3‎

SESSION SYNOPSIS: Interest in psychedelic-assisted therapies (PAT) has increased dramatically based ‎on clinical research showing that Psilocybin (magic mushrooms), MDMA, and Ketamine can be ‎effective for treatment-resistant depression, PTSD, addictions, end-of-life anxiety, and obsessive-‎compulsive disorder. However, it is important to recognize that these benefits are attained within ‎contexts that provide specialized preparation for the psychedelic experience, active support during, ‎and structured integration sessions for follow-up.  Although it is tempting to view psychedelics as a ‎‎“magic bullet” that can permanently solve personal problems and mental health conditions, it is ‎probably more accurate to think of them as medicines that induce a state of increased brain plasticity, ‎also known as a "pivitol mental state". This neuroplasticity facilitates new ways of thinking, feeling, ‎and behaving for those who use it medicinally (Carhart-Harris & Friston, 2019). With this ‎understanding, it becomes increasingly important to 1) prepare the brain/nervous system for the shift ‎experienced during a psychedelic session, and 2) to take advantage of the increased flexibility created ‎by the experience in the days following a psychedelic session. In addition to incorporating targeted ‎psychotherapy, it can also be helpful to include mental state training in the form of neurofeedback ‎and neurofeedback-guided meditation (neuromeditation) into PAT’s.  This workshop will present the ‎neuroscience, research findings, and practice of psychedelic assisted therapies. We will explore this ‎data in the context of the entropic model of consciousness, and conditions related to therapeutic ‎outcomes. We will discuss how neurofeedback therapies are poised to offer a method to support the ‎various states of awareness that underlie positive outcomes as well as practices that help sustain the ‎‎“afterglow” after a psychedelic session. A model for neurofeedback supported PAT’s will be presented ‎along with case study data.‎

  • Basic Science
  • Intermediate
  • ‎75% Clinical/25% Research‎


  • Describe the science behind psychedelic assisted therapies (PAT's)‎
  • Discuss the entropic model of consciousness and its connection to mental health
  • Apply bio and neurofeedback approaches to the preparation and integration phases of PAT's
  • Explain a model of neurofeedback supported PAT

TARGET AUDIENCE: Clinicians interested in learning more about bio- and neurofeedback approaches ‎to complement and advance psychedelic assisted therapies.‎

DIVERSITY CONSIDERATIONS: We strongly emphasize the importance of recognizing and honoring ‎diversity-in all its forms. The approaches taught in this workshop are discussed in the context of ‎individual differences based on a person's culture, background, and neurological state.‎


2 pm - 6 pm‎ - Half Day Workshop
WS11: EEG: Linking Neurology, Psychiatry, and Neurotherapy

Presented By: ‎

  • Ronald Swatzyna, PhD
  • Harry Kerasidis, MD
  • Robert "Rusty" Turner, MD

SESSION SYNOPSIS: Normally, by the time most patients consider neurofeedback, they have failed ‎multiple medication trials and non-‎medication treatments and are frustrated with the trial-and-error ‎method. A 2015 a study linked psychiatric ‎medication failure to four EEG phenotypes: focal slowing, ‎spindling excessive beta, encephalopathy (EN), and ‎isolated epileptiform discharges (IEDs). The ‎significance of the focal or diffuse slowing and spindling excessive beta ‎is easily discerned in qEEG ‎brain mapping. However, IEDs are either artifacted out or averaged out in qEEG ‎processing. Only ‎neurologists, through visual interpretation of the EEG, can diagnose EN or identify the presence ‎IEDs. ‎This is beyond the scope of practice for PhD or masters level clinicians. Encephalopathy is a term for any diffuse disease of the brain that alters brain function or structure. ‎Symptoms ‎include progressive loss of memory and cognitive abilities, over time subtle personality ‎change, inability to ‎concentrate, and fatigue. How to differentiate encephalopathic features from ‎drowsy and sleep states including ‎case examples of encephalopathies, metabolic, neurodegenerative, ‎and structural disorders will be discussed.  Isolated Epileptiform Discharges refers to spike and wave or sharp and slow activity in nonepileptic ‎individuals. ‎Various terms have been used to describe epileptiform activity such as IEDs, subclinical ‎epileptiform activity, ‎epileptiform discharges, and interictal epileptiform discharges. The importance of ‎differentiating normal features ‎of EEG from epileptiform features will be discussed as well as the ever-‎present danger of over interpretation or ‎under interpretation of EEG abnormalities, with multiple ‎examples of both errors. This workshop with cover the early work on phenotypes and vigilance modeling, including the trait and ‎state of the ‎four primary categories that predict treatment failure. We will discuss the vital nature of ‎identifying EN and IEDs ‎and how the EEG can be useful to guide neurotherapy protocol development. ‎The ethical considerations for the ‎neurotherapist will be delineated with an emphasis on the ‎importance of collaboration among ourselves, ‎neurologist, psychiatrists, and other mental health ‎providers. Lastly, we will discuss how to collect and categorize ‎clinical electrographic data for the ‎purpose of joining an international collaborative effort to further the research in ‎our field. ‎

  • Hot Topics
  • Intermediate
  • ‎50% Clinical/50% Research‎


  • Define a refractory case, the four primary causes of treatment failure.‎
  • Evaluate which cases should be referred for an EEG interpretation.‎
  • Identify feature in the EEG that may imply encephalopathy‎
  • Identify features in the EEG that may imply isolated epileptiform discharges ‎

TARGET AUDIENCE: People in any field that utilize the EEG.  Members of our community who want to ‎help forward our field into the mainstream. ‎

DIVERSITY CONSIDERATIONS: Currently, Neurofeedback can be expensive and difficult to explain. If we ‎want to progress our society forwards, ‎cultures who are impacted the most by institutional racism and ‎need more mental health assistance, we need the ‎field to become more accessible for all people. By ‎discussing how to link our fields to other  “mainstream” practices, we hope to bring Neurotherapy to ‎society at large in a major way. ‎



Wednesday, March 23, 2022‎

Thursday, March 24, 2022‎

Friday, March 25, 2022‎

Friday March 25, 2022 CONTINUED

Saturday, March 26, 2022‎

Saturday, March 26, 2022 CONTINUED



Follow AAPBiofeedback on Twitter
Follow 121999491198448 on Facebook
image widget